s6y
Company name or ticker
Search
Raphael Pharmaceutical Inc.
8-K
Current report filing
Filed
Monday, October 24, 2022
Period
Oct 7, 2022
Accession number
0001213900-22-065828
Documents
CURRENT REPORT
8-K
XBRL LABEL FILE
EX-101.LAB
XBRL PRESENTATION FILE
EX-101.PRE
XBRL SCHEMA FILE
EX-101.SCH
On sec.gov
Filing index
All files
Complete submission text
SGML header